Baker Hughes Reports 11% Rise in Q4 Adjusted Profit Driven by LNG Demand 
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
Noble Corporation Secures $1.3 Billion in New Contracts, Strengthening Offshore Drilling Backlog 
Samsung Set to Begin HBM4 Production for Nvidia and AMD 
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns 
Delta Air Lines Operates Reduced Flight Schedule as Winter Storm Disrupts U.S. Travel 
Ryanair Profit Slumps in Q3 After Italy Antitrust Fine Despite Revenue Growth 
Goldman Sachs CEO David Solomon’s 2025 Pay Soars to $47 Million After Strong Deal-Making Year 
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal 
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
CN Energy Group Inc. Stock Slides After Nasdaq Delisting Notice Over Bid Price Rule 
Microsoft Restores Microsoft 365 Services After Widespread Outage 
LVMH Succession Uncertainty Raises Governance Concerns Among Shareholders 
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 
RICHMOND, Calif., May 11, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced the company plans to participate in the B. Riley & Co. Institutional Investor Conference in Santa Monica, California.
Ekso Bionics’ management is scheduled to present Wednesday, May 24, 2017 at 10:00 a.m. PDT. A live and archived webcast of the presentation will be available on the investors section of the company’s website at: www.eksobionics.com.
About Ekso Bionics®
Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical, industrial and defense applications. Founded in 2005, the company continues to build upon its unparalleled expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe, to providing research for the advancement of R&D projects intended to benefit U.S. defense capabilities. The company is headquartered in the Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO. For more information, visit: www.eksobionics.com.
Media Contact: Carrie Yamond/Rajni Dhanjani 212-867-1788 [email protected] Investor Contact: Debbie Kaster 415-937-5403 [email protected]
